BerandaASRT • NASDAQ
add
Assertio Holdings Inc
Tutup sebelumnya
$0,74
Rentang hari
$0,72 - $0,75
Rentang tahun
$0,51 - $1,38
Kapitalisasi pasar
68,97 jt USD
Volume Rata-Rata
223,79 rb
Rasio P/E
-
Hasil dividen
-
Bursa utama
NASDAQ
Keuangan
Laporan Pendapatan
Pendapatan
Laba bersih
| (USD) | Mar 2025info | Perubahan Y/Y |
|---|---|---|
Pendapatan | 26,49 jt | -18,37% |
Biaya operasional | 31,65 jt | 27,15% |
Laba bersih | -13,54 jt | -200,24% |
Margin laba bersih | -51,12 | -267,77% |
Penghasilan per saham | -0,04 | -200,00% |
EBITDA | -3,68 jt | -276,77% |
Tarif pajak efektif | -1,84% | — |
Neraca
Total aset
Total liabilitas
| (USD) | Mar 2025info | Perubahan Y/Y |
|---|---|---|
Investasi tunai jangka pdk | 87,32 jt | 8,15% |
Total aset | 286,43 jt | 1,58% |
Total liabilitas | 177,90 jt | 20,63% |
Total ekuitas | 108,53 jt | — |
Saham yang beredar | 95,78 jt | — |
Harga terhadap nilai buku | 0,65 | — |
Tingkat pengembalian aset | -11,33% | — |
Tingkat pengembalian modal | -20,87% | — |
Arus Kas
Perubahan kas bersih
| (USD) | Mar 2025info | Perubahan Y/Y |
|---|---|---|
Laba bersih | -13,54 jt | -200,24% |
Kas dari operasi | -12,54 jt | -267,00% |
Kas dari investasi | -2,94 jt | — |
Kas dari pembiayaan | -111,00 rb | 46,12% |
Perubahan kas bersih | -15,58 jt | -313,42% |
Arus kas bebas | -7,64 jt | -182,12% |
Tentang
Assertio Therapeutics, Inc. is an American specialty pharmaceutical company. It mainly markets products for treatment in neurology, pain and diseases of the central nervous system. Depomed was founded in 1995 and is headquartered in Newark, California. It is a publicly traded company on NASDAQ, with several products approved by the United States Food and Drug Administration. On August 15, 2018, the company announced its name change from Depomed, Inc., to Assertio Therapeutics, Inc. As of 2019, Assertio markets three products approved by the FDA: Gralise, Cambia, and Zipsor. Wikipedia
Didirikan
1995
Kantor pusat
Situs
Karyawan
58
